// App-Quantinova.ai

10567 : Outcomes for cancer patients on systemic anti-cancer therapies during the COVID-19 pandemic from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.

Researchers

Presenter

  • Valerie Crolley

Principal Investigators

  • Daire Hanna

  • Nalinie Joharatnam-Hogan

  • Neha Chopra

  • Ekin Bamac

  • Meera Desai

  • Yuk-Chun Lam

  • Sabiq Dipro

  • Ruhi Kanani

  • Jack Benson

  • William Wilson

  • Thomas Andrew Fox

  • Kai-Keen Shiu

  • Martin Forster

  • John A. Bridgewater

  • Daniel Hochhauser

  • Khurum Hayat Khan

Medical Centers

  • Bart's Cancer Institute, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Kings College London, London, United Kingdom

  • University College London Hospital, Middlsex, United Kingdom

  • Kings College London, London, United Kingdom

  • West Middlesex University Hospital, London, United Kingdom

  • Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved